tm
Seeing Is Believing
tm
Seeing Is Believing
LXEO is currently covered by 6 analysts with an average price target of $15.08. This is a potential upside of $9.31 (161.35%) from yesterday's end of day stock price of $5.77.
Lexeo Therapeutics, Common Stock's activity chart (see below) currently has 35 price targets and 40 ratings on display. The stock rating distribution of LXEO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 9.52% with an average time for these price targets to be met of 30.71 days.
Highest price target for LXEO is $20, Lowest price target is $10, average price target is $15.67.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 12-Jan-2026. First documented stock forecast 27-Nov-2023.
Currently out of the existing stock ratings of LXEO, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jun-2024
$10
$4.28 (74.83%)
$13
2 months 25 days ago
(12-Jan-2026)
0/11 (0%)
$2.57 (34.59%)
Buy Since 27-Nov-2023
$17
$11.28 (197.20%)
$17
2 months 25 days ago
(12-Jan-2026)
0/6 (0%)
$9.57 (128.80%)
Buy Since 19-Nov-2025
$19
$13.28 (232.17%)
$19
4 months 6 days ago
(30-Nov-2025)
0/2 (0%)
$10.08 (113.00%)
Buy Since 27-Nov-2023
$18
$12.28 (214.69%)
$21
5 months 21 days ago
(17-Oct-2025)
0/4 (0%)
$8.42 (87.89%)
Buy Since 27-Nov-2023
$20
$14.28 (249.65%)
$9
6 months ago
(07-Oct-2025)
1/6 (16.67%)
$11.66 (139.81%)
64
What is LXEO (Lexeo Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on LXEO (Lexeo Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on LXEO (Lexeo Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on LXEO (Lexeo Therapeutics, Common Stock)?
Which analyst is the currently most bullish on LXEO (Lexeo Therapeutics, Common Stock)?
Which analyst is the currently most reserved on LXEO (Lexeo Therapeutics, Common Stock)?
